Unknown

Dataset Information

0

Virus-like particle vaccines containing F or F and G proteins confer protection against respiratory syncytial virus without pulmonary inflammation in cotton rats.


ABSTRACT: Vaccine-enhanced disease has been a major obstacle in developing a safe vaccine against respiratory syncytial virus (RSV). This study demonstrates the immunogenicity, efficacy, and safety of virus-like particle (VLP) vaccines containing RSV F (F VLP), G (G VLP), or F and G proteins (FG VLP) in cotton rats. RSV specific antibodies were effectively induced by vaccination of cotton rats with F VLP or FG VLP vaccines. After challenge, lung RSV clearance was observed with RSV F, G, FG VLP, and formalin inactivated RSV (FI-RSV) vaccines. Upon RSV infection, cotton rats with RSV VLP vaccines were protected against airway hyper-responsiveness and weight loss, which are different from FI-RSV vaccination exhibiting vaccine-enhanced disease of airway obstruction, weight loss, and severe histopathology with eosinophilia and mucus production. FG VLP and F VLP vaccines did not cause pulmonary inflammation whereas G VLP induced moderate lung inflammation with eosinophilia and mucus production. In particular, F VLP and FG VLP vaccines were found to be effective in inducing antibody secreting cell responses in bone marrow and lymphoid organs as well as avoiding the induction of T helper type 2 cytokines. These results provide further evidence to develop a safe RSV vaccine based on VLP platforms.

SUBMITTER: Hwang HS 

PROVIDER: S-EPMC5443399 | biostudies-literature | 2017 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

Virus-like particle vaccines containing F or F and G proteins confer protection against respiratory syncytial virus without pulmonary inflammation in cotton rats.

Hwang Hye Suk HS   Kim Ki-Hye KH   Lee Youri Y   Lee Young-Tae YT   Ko Eun-Ju EJ   Park SooJin S   Lee Jong Seok JS   Lee Byung-Cheol BC   Kwon Young-Man YM   Moore Martin L ML   Kang Sang-Moo SM  

Human vaccines & immunotherapeutics 20170127 5


Vaccine-enhanced disease has been a major obstacle in developing a safe vaccine against respiratory syncytial virus (RSV). This study demonstrates the immunogenicity, efficacy, and safety of virus-like particle (VLP) vaccines containing RSV F (F VLP), G (G VLP), or F and G proteins (FG VLP) in cotton rats. RSV specific antibodies were effectively induced by vaccination of cotton rats with F VLP or FG VLP vaccines. After challenge, lung RSV clearance was observed with RSV F, G, FG VLP, and formal  ...[more]

Similar Datasets

| S-EPMC8741018 | biostudies-literature
| S-EPMC4171188 | biostudies-literature
| S-EPMC5770062 | biostudies-literature
| S-EPMC5987903 | biostudies-literature
| S-EPMC2887800 | biostudies-literature
| S-EPMC4620468 | biostudies-literature
| S-EPMC7416943 | biostudies-literature
| S-EPMC3978801 | biostudies-other
| S-EPMC8484905 | biostudies-literature
| S-EPMC3164432 | biostudies-literature